Cargando…

Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs

INTRODUCTION: The Clinical and Translational Science Awards (CTSA) Consortium, a network of academic health care institutions with CTSA hubs, is charged with improving the national clinical and translational research enterprise. The CTSA Consortium and the NIH National Center for Advancing Translati...

Descripción completa

Detalles Bibliográficos
Autores principales: Welch, Lisa C., Tomoaia-Cotisel, Andrada, Chang, Hong, Mendel, Peter, Etchegaray, Jason M., Qureshi, Nabeel, Fenwood-Hughes, Marguerite, Parajulee, Anshu, Selker, Harry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057429/
https://www.ncbi.nlm.nih.gov/pubmed/33948287
http://dx.doi.org/10.1017/cts.2020.565
_version_ 1783680834012708864
author Welch, Lisa C.
Tomoaia-Cotisel, Andrada
Chang, Hong
Mendel, Peter
Etchegaray, Jason M.
Qureshi, Nabeel
Fenwood-Hughes, Marguerite
Parajulee, Anshu
Selker, Harry P.
author_facet Welch, Lisa C.
Tomoaia-Cotisel, Andrada
Chang, Hong
Mendel, Peter
Etchegaray, Jason M.
Qureshi, Nabeel
Fenwood-Hughes, Marguerite
Parajulee, Anshu
Selker, Harry P.
author_sort Welch, Lisa C.
collection PubMed
description INTRODUCTION: The Clinical and Translational Science Awards (CTSA) Consortium, a network of academic health care institutions with CTSA hubs, is charged with improving the national clinical and translational research enterprise. The CTSA Consortium and the NIH National Center for Advancing Translational Sciences implemented the Common Metrics Initiative comprised of standardized metrics and a shared performance improvement framework. This article summarizes hubs’ perspectives on its value during the initial implementation. METHODS: The value was assessed across 58 hubs. Survey items assessed change in perceived ability to manage performance and advance clinical and translational science. Semi-structured interviews elicited hubs’ perspectives on meaningfulness and value-added of the Common Metrics Initiative and hubs’ recommendations. RESULTS: Hubs considered their abilities to manage performance to have improved, but there was no change in perceived ability to advance clinical and translational science. The initiative added value by providing a formal structured process, enabling strategic conversations, facilitating improvements in processes, providing an external impetus for improvement, and providing justification for funds invested. Hubs were concerned about the usefulness of the metrics chosen and whether the value-added was sufficient relative to the effort required. Hubs recommended useful benchmarking, disseminating best practices and promoting peer-to-peer learning, and expanding the use of data to inform the initiative. CONCLUSIONS: Implementing Common Metrics and a performance improvement framework yielded concrete short-term benefits, but concerns about usefulness remained, particularly considering the effort required. The Common Metrics Initiative should focus on facilitating cross-hub collaboration around metrics that address high-priority impact areas for individual hubs and the Consortium.
format Online
Article
Text
id pubmed-8057429
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-80574292021-05-03 Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs Welch, Lisa C. Tomoaia-Cotisel, Andrada Chang, Hong Mendel, Peter Etchegaray, Jason M. Qureshi, Nabeel Fenwood-Hughes, Marguerite Parajulee, Anshu Selker, Harry P. J Clin Transl Sci Research Article INTRODUCTION: The Clinical and Translational Science Awards (CTSA) Consortium, a network of academic health care institutions with CTSA hubs, is charged with improving the national clinical and translational research enterprise. The CTSA Consortium and the NIH National Center for Advancing Translational Sciences implemented the Common Metrics Initiative comprised of standardized metrics and a shared performance improvement framework. This article summarizes hubs’ perspectives on its value during the initial implementation. METHODS: The value was assessed across 58 hubs. Survey items assessed change in perceived ability to manage performance and advance clinical and translational science. Semi-structured interviews elicited hubs’ perspectives on meaningfulness and value-added of the Common Metrics Initiative and hubs’ recommendations. RESULTS: Hubs considered their abilities to manage performance to have improved, but there was no change in perceived ability to advance clinical and translational science. The initiative added value by providing a formal structured process, enabling strategic conversations, facilitating improvements in processes, providing an external impetus for improvement, and providing justification for funds invested. Hubs were concerned about the usefulness of the metrics chosen and whether the value-added was sufficient relative to the effort required. Hubs recommended useful benchmarking, disseminating best practices and promoting peer-to-peer learning, and expanding the use of data to inform the initiative. CONCLUSIONS: Implementing Common Metrics and a performance improvement framework yielded concrete short-term benefits, but concerns about usefulness remained, particularly considering the effort required. The Common Metrics Initiative should focus on facilitating cross-hub collaboration around metrics that address high-priority impact areas for individual hubs and the Consortium. Cambridge University Press 2020-12-14 /pmc/articles/PMC8057429/ /pubmed/33948287 http://dx.doi.org/10.1017/cts.2020.565 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Research Article
Welch, Lisa C.
Tomoaia-Cotisel, Andrada
Chang, Hong
Mendel, Peter
Etchegaray, Jason M.
Qureshi, Nabeel
Fenwood-Hughes, Marguerite
Parajulee, Anshu
Selker, Harry P.
Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title_full Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title_fullStr Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title_full_unstemmed Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title_short Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs
title_sort do common metrics add value? perspectives from nih clinical and translational science awards (ctsa) consortium hubs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057429/
https://www.ncbi.nlm.nih.gov/pubmed/33948287
http://dx.doi.org/10.1017/cts.2020.565
work_keys_str_mv AT welchlisac docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT tomoaiacotiselandrada docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT changhong docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT mendelpeter docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT etchegarayjasonm docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT qureshinabeel docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT fenwoodhughesmarguerite docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT parajuleeanshu docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs
AT selkerharryp docommonmetricsaddvalueperspectivesfromnihclinicalandtranslationalscienceawardsctsaconsortiumhubs